In a letter to Prime Minister Narendra Modi, the Indian Medical Association (IMA) said it will offer the services of more than 3 lakhs of its...
Most of the promising COVID-19 vaccine candidates currently completing phase 3 clinical trials belong to the cold-chain category, meaning that they need to be stored and...
Serum Institute of India (SII) has partnered with global pharma giant AstraZeneca and Oxford University for the COVID-19 vaccine candidate 'Covishield'
According to a journal study published by the researchers of the University of Colorado Boulder and Harvard University, the frequency of testing is more important to...
The World Health Organisation says it is not yet known whether a pregnant woman with COVID-19 can pass the virus to her foetus or baby during...
According to Health Minister Satyendar Jain, there is sufficient infrastructure and equipment available in the national capital to vaccinate its entire population in a few weeks...
According to CSIR-Centre for Cellular and Molecular Biology researchers, dry swab technique can be used for RT-PCR testing for COVID-19 with sensitivity and specificity similar to...
The researchers from China's Academy of Military Medical Sciences found that coronavirus sticks to a receptor on the human cells that usually binds to HDL (high-density...
A new study published in the New England Journal of Medicine (NEJM), sheds light on the genetic risk factors that make individuals more or less susceptible...
According to India Child Well-being Report 2020, released by World Vision India, many children in the country are no longer having three meals a day and...
NDTV speaks with top doctors and experts to know about the road to recovery in country’s ongoing fight against coronavirus
AstraZeneca and Oxford University acknowledged a manufacturing error that is raising doubts about preliminary results of their experimental COVID-19 vaccine candidate